Mingxin New Material (605068.SH) plans to establish a joint venture to carry out research and development, manufacturing, and sales of flexible hands.
Ming Xinxu Teng (605068.SH) announced that the company and Shanghai Qingbao intend to jointly invest in setting up Xiuqing Lingdong in Shanghai...
Mingxin New Material (605068.SH) announced that the company plans to establish a joint venture with Shanghai Qingbao in Shanghai to invest in XQLD (Shanghai) Intelligent Technology Co., Ltd. (referred to as the "joint venture company") to carry out research and development, manufacturing, and sales of agile hands. The registered capital of the joint venture company is 12 million yuan, with the company planning to invest 7.8 million yuan from its own funds, accounting for 65%, and Shanghai Qingbao to invest 4.2 million yuan in intellectual property, accounting for 35%. On October 20, 2025, the company and Shanghai Qingbao jointly signed the "Joint Venture Agreement".
The above-mentioned joint investment with related parties to establish a joint venture company is beneficial for the company to leverage the professional experience and industrial foundation of the cooperation party, reduce the trial and error costs and investment risks of entering new fields, and promote the diversification of the company's business direction. After the completion of this transaction, the company will hold 65% equity in the joint venture company, which will become a wholly-owned subsidiary of the company, included in the company's consolidated financial statements, in line with the company's strategic development plan.
Related Articles

SUNART RETAIL (06808) issues profit warning, expecting a mid-term shareholders' loss of approximately RMB 140 million.

Alphabet's (GOOGL.US) self-driving department Waymo is being investigated by the NHTSA for allegedly violating rules regarding stopping for school buses.

Roche (RHHBY.US) has been approved to use "Ocrelizumab" to treat lupus nephritis.
SUNART RETAIL (06808) issues profit warning, expecting a mid-term shareholders' loss of approximately RMB 140 million.

Alphabet's (GOOGL.US) self-driving department Waymo is being investigated by the NHTSA for allegedly violating rules regarding stopping for school buses.

Roche (RHHBY.US) has been approved to use "Ocrelizumab" to treat lupus nephritis.

RECOMMEND

Why European Automakers Are Opposing Dutch Sanctions
20/10/2025

Domestic Commercial Rockets Enter Batch Launch Era: Behind the Scenes a Sixfold Cost Gap and Reusability as the Key Breakthrough
20/10/2025

Multiple Positive Catalysts Lift Tech Stocks; UBS Elevates China Tech to Most Attractive, Citing AI as Core Rationale
20/10/2025